Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - TETRAPHASE PHARMACEUTICALS INC | ttph-ex321_9.htm |
| EX-31.2 - EX-31.2 - TETRAPHASE PHARMACEUTICALS INC | ttph-ex312_6.htm |
| EX-31.1 - EX-31.1 - TETRAPHASE PHARMACEUTICALS INC | ttph-ex311_8.htm |
| 10-Q - 10-Q - TETRAPHASE PHARMACEUTICALS INC | ttph-10q_20180930.htm |
Exhibit 32.2
Certification of Principal Financial Officer
pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the quarterly report on Form 10-Q of Tetraphase Pharmaceuticals, Inc. (the “Company”) for the period ended September 30, 2018, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Christopher Watt, as Principal Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his knowledge:
|
|
(1) |
the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and |
|
|
(2) |
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Dated: November 8, 2018
|
|
|
/s/ Christopher Watt |
|
Christopher Watt |
|
Senior Vice President, Finance (Principal Financial Officer and Principal Accounting Officer) |